Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats

AIM: The aim of this study was to investigate the hypothesis that the opioid system is involved in the development of hepatic fibrosis. METHODS: The effect of naltrexone (an opioid receptor antagonist) on hepatic fibrosis in bile duct ligated (BDL) or sham rats was assessed by histology and hepatic...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ebrahimkhani, M R, Kiani, S, Oakley, F, Kendall, T, Shariftabrizi, A, Tavangar, S M, Moezi, L, Payabvash, S, Karoon, A, Hoseininik, H, Mann, D A, Moore, K P, Mani, A R, Dehpour, A R
Format: Artigo
Langue:Inglês
Publié: BMJ Group 2006
Sujets:
Liver
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860108/
https://ncbi.nlm.nih.gov/pubmed/16543289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2005.076778
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires